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Background: Physical inactivity is a global pandemic. The population attributable fraction (PAF) of type 2 diabetes
mellitus (T2DM) associated with physical inactivity ranges from 3% to 40%. The purpose of this systematic review
was to determine the best estimate of PAF for T2DM attributable to physical inactivity and absence of sport
participation or exercise for men and women.
Methods: We conducted a systematic review that included a comprehensive search of MEDLINE, EMBASE,
SportDiscus, and CINAHL (1946 to April 30 2013) limited by the terms adults and English. Two reviewers screened
studies, extracted PAF related data and assessed the quality of the selected studies. We reconstructed 95% CIs for
studies missing these data using a substitution method.
Results: Of the eight studies reporting PAF in T2DM, two studies included prospective cohort studies (3 total) and
six were reviews. There were distinct variations in quality of defining and measuring physical inactivity, T2DM and
adjusting for confounders. In the US, PAFs for absence of playing sport ranged from 13% (95% CI: 3, 22) in men and
29% (95% CI: 17, 41) in women. In Finland, PAFs for absence of exercise ranged from 3% (95% CI: -11, 16) in men to
7% (95% CI: -9, 20) in women.
Conclusions: The PAF of physical inactivity due to T2DM is substantial. Physical inactivity is a modifiable risk factor
for T2DM. The contribution of physical inactivity to T2DM differs by sex; PAF also differs if physical inactivity is
defined as the absence of ‘sport’ or absence of ‘exercise’.
Keywords: Population attributable fraction (PAF), Physical inactivity, Type 2 diabetes (DM-2), Systematic reviewBackground
Physical inactivity, a global pandemic [1], is one of the
most serious public health problems of the 21st century
in terms of consequences and cost [2-4]. Annually, the
global mortality attributable to physical inactivity is ap-
proximately 3.3 million [5]. Globally, physical inactivity
is identified as the fourth leading risk factor for mortality
among adults [5]; it is an independent risk factor for
major chronic diseases [6,7]. Physical inactivity is also
associated with substantial economic burden across the* Correspondence: karim.khan@ubc.ca
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1.6 billion in Switzerland (1999 prices) to $US 24 billion
in the USA (1999 prices) [4].
Type 2 diabetes mellitus (T2DM) also imposes a signifi-
cant health and economic burden on North American
health care system [8]. In the US alone (2011), the age–
adjusted incidence increased 117% from 3.5 to 8.3 per
1,000 persons between 1980 and 2011 [9]. The cases of
T2DM were projected to increase from 12 million in 2000
to 39 million by 2050 (i.e. a prevalence increase from 4.4%
to 9.7% in 2050) [10]. The direct costs associated with
T2DM was approximately $US 44.1 billion per year or
almost $US 6000 per person per year (1997 prices) [11].
Furthermore, the cost of T2DM attributable to physical
inactivity (absence of leisure-time activity) ranged fromal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Physical activity benefits at least 23 different health
conditions [13,14]. Despite this, fewer than 50% of the
people engage in sufficient physical activity to reap such
benefits [15,16]. Prospective studies demonstrate that
physical inactivity is an independent and modifiable risk
factor for T2DM [17]. Specifically, physical activity inter-
ventions reduced the risk of developing diabetes [18-20].
A method of quantifying the burden of T2DM attrib-
utable to physical inactivity is population attributable
fraction (PAF). PAF takes into account the degree of asso-
ciation between a risk factor and the incidence of a disease
(i.e., relative risk) and the public health importance of this
risk factor at a population level. Specifically, PAF estimates
the proportion of disease cases (i.e., T2DM cases) that are
attributable to a risk factor of interest (i.e., physical in-
activity) among all disease cases in a population [21].
To date, PAF estimates for the excess cases of T2DM
vary from 3% due to lack of exercise in Finland to 40%
in Canada due to lack of moderate-vigorous physical ac-
tivity [13-15]. Some of this variability is due to variation in
calculating PAF based on age-, gender-, region-specific
factors. But there has been no systematic review that has
assessed the PAF of T2DM attributable to physical inactiv-
ity in men and women. Also, none has used recent ad-
vances in PAF as outlined by Laaksonen [13]. Examining
the quality of these discrepant estimates and underlying
reasons for the observed variation is important as it will
provide policymakers with a guide to which of the original
studies should carry most weight. Hence, our primary ob-
jective was to quantify the PAF of T2DM attributable to
physical inactivity and absence of sport participation or
exercise for men and women.
Methods
Data sources and search strategy
In accordance with the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis (PRISMA) state-
ment [22] and Cochrane Collaboration guidelines [23],
we [HAT, JCD, KMK] conducted a comprehensive
search of MEDLINE, EMBASE, SportDiscus, and
CINAHL. We limited our search results to adults aged
19-65 years and studies published in English. We in-
cluded search terms the MeSH headings: diabetes,
physical activity, fitness, risk assessment. The search
strategy detailed in Figure 1(B) includes studies pub-
lished between 1946 and April 30 2013. We manually
searched all references of articles selected for full text
review to identify additional relevant papers.
Study selection and eligibility criteria
We (HAT, JCD) included peer reviewed, published stud-
ies that (i) estimated PAF or population attributable ratio(PAR) using modeling on raw data from a prospective
cohort design or (ii) published adjusted relative risk
(RRadj) and prevalence of the risk factor of interest –
physical inactivity [24]. Of note, review studies were in-
cluded if their RRadj estimates were based on prospective
cohort data. Based on title and abstract review, we ex-
cluded studies that: 1) used an exposure unrelated to
physical inactivity), 2) used an outcome that was not
T2DM, 3) used an inappropriate study design for esti-
mating PAF/PAR (i.e., cross-sectional, case-control or
retrospective studies). Based on full text review, we ex-
cluded studies that: 1) did not contain a PAF estimate,
2) did not detail the independent contribution of phys-
ical inactivity, 3) used an inappropriate study design for
estimating PAF/PAR (i.e., cross-sectional, case-control
or retrospective studies), 4) the primary outcome was
not T2DM, 5) were duplicates. Eight full-text articles
met the inclusion criteria – four from our search strat-
egy and four from our review of the reference lists of all
articles selected for full text review. All discrepancies
were resolved by discussion and consultation with a co-
author (KMK). Figure 1(A) details the process of study
selection for this systematic review.
Data extraction
Two raters (HAT, JCD) independently extracted data
from each study and any discrepancies were discussed
and reviewed by a third party (KMK). We developed a
list of data extraction topics for the studies included in
this systematic review (Additional file 1: Table S1 and
Additional file 2: Table S2). These items were: author’s
name, year of publication, country, journal name, study
design, sample size, sample characteristic, length of fol-
low up, operational definition for exposure (physical in-
activity), operational definition for outcome (T2DM),
level of adjustment for confounders, PAF estimates and
calculation method used to estimate PAF (Additional file 1:
Table S1 and Additional file 2: Table S2).
Exposure, outcome and outcome measures for data
synthesis
Our primary exposure of interest for population at-
tributable fraction (PAF) estimates was physical inactivity.
Physical inactivity was defined as total physical activ-
ity insufficient to meet recommended guidelines, that
is ≤ 150 minutes of moderate-intensity or ≤ 75 minutes
of vigorous-intensity aerobic physical activity per week in
bouts of at least 10 minutes duration accumulated across
occupational, transport-related, domestic or leisure-time
domains [5]. Leisure –time activity domains includes exer-
cise, sport and unstructured recreation [14,25,26]. Exercise
[27] is a planned, structured and repetitive physical activ-
ity with the purpose of improving and/or maintaining
physical fitness. i.e. both exercise and sport are subsets of
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4     1 or 2 or 3 (429966)
5     physical activit$.mp. (51021)
6     physical inactivity.mp. (3541)
7     fitness.mp. (48520)
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Figure 1 A Flow diagram showing study selection (1A) and database search (1B) for systematic review of studies on population
attributable fraction (PAF) of type 2 diabetes (T2DM) due to physical inactivity in adults.
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Sport is a subset of exercise undertaken either individually
or as a part of a team where participants adhere to a com-
mon set of rules or expectation and a defined goal to win
[28]. Physical inactivity was either self-reported or directly
measured by accelerometry.
Our primary outcome of interest for estimating popu-
lation attributable fraction (PAF) was T2DM defined
as: 1) hyperglycemia ascertained by fasting plasma
glucose ≥ 7.0 mmol/l (126 mg/dl) or 2-h plasma glu-
cose ≥ 11.1 mmol/l (200 mg/dl) or 2) self report with
validation from a registry, medical record or reim-
bursement plan [29,30].
Population attributable fraction (PAF) or proportion
(PAR) was defined as the excess number of cases of
T2DM attributable to physical inactivity or low physical
fitness that is estimated by the following formula or one
of its variant [31]:
PAF
Pe RRadj‐1ð Þ
RRadj‐1ð Þ  100
Where, Pe is population prevalence of exposure and
RRadj is an adjusted relative risk.
Of note, we estimated the confidence intervals (95%
CI) for PAF using the substitution method when these
data were not reported [32]. All calculations done by the
authors are labeled with an ‘a’ in Additional file 2: Table S2.
This method used the upper and lower limits of RR in
attributable risk (AR) formula.
Due to study design, sample and analytic heterogen-
eity, a meta-analysis of these data to determine PAF for
T2DM was not conducted.
Quality assessment
Because our systematic review consisted of both prospect-
ive cohort studies and reviews, a published quality assess-
ment checklist suitable for this study was not available.
Therefore, we developed a seven-item quality assessment
form. This form was created after reviewing potentially
relevant checklists such as the STROBE [33,34]. From
these examples, we created and modified questions rele-
vant to assessing the quality of the PAF estimates included
in this systematic review. The questions were structured
so that they could be applied across all included studies
and study designs (Additional file 3: Table S3). All quality
assessment questions were reviewed by an expert in the
field. This quality assessment was not validated. We used
dichotomized answers (+: yes, -: no) for the quality assess-
ment questions to create a score out of 7. Two authors
(JCD, HAT) independently evaluated each study and any
discrepancies were discussed and reviewed by a third
author (KMK). Below, we outline each of the criteria
included in the quality assessment.Quality assessment questions
Question 1: Was a clear definition provided for the
exposure (physical inactivity)? Physical inactivity was
defined as the total activity that does not meet the recom-
mended guidelines of ≤ 150 minutes of moderate-intensity
or ≤ 75 minutes of vigorous-intensity aerobic physical
activity per week in bouts of at least 10 minutes duration
accumulated across occupational, transport-related, do-
mestic or leisure-time activity domains [5].
Question 2: Was the exposure (physical inactivity)
measured objectively? Physical inactivity can either be
measured subjectively using validated self reported ques-
tionnaires or objectively using accelerometers [35].
Question 3: Was a clear clinical definition provided
for the outcome (type 2 diabetes)? T2DM was defined
using hyperglycemia cutoffs as listed above.
Question 4: Was the outcome ascertained by objective
measures or if self reported confirmed by other
measures? The current diagnostic criteria is requires a
fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dl) or a 2-h
plasma glucose ≥ 11.1 mmol/l (200 mg/dl) [29,30].
Question 5: Was the analysis based on raw data from
a prospective cohort study? One of the PAF assumptions
is causality; therefore, only prospective studies were
deemed appropriate for estimating PAF [21].
Question 6: Was the follow up time provided? PAF is
subject to follow up time bias [21]. Specifically, a shorter
follow up time is associated with an overestimated PAF
while a longer follow up time is associated with an under-
estimated PAF.
Question 7: Was population attributable fraction
(PAF) or proportion (PAR) fully adjusted? PAFs are
subject to confounding bias [24]. The partial adjustment
method is a popular method of calculating PAF. It uses
published adjusted RR and prevalence of exposure in
this formula [24]:
PAF ¼ Pe RRadj‐1ð Þ
RRadj‐1
 100
The partially adjusted method can yield severely biased
PAF estimates [36] because the confounding variables
are not adequately adjusted. For instance, incomplete ad-
justment for confounding by age and sex can lead to
17% overestimation in PAF [36]. Therefore modeling all
known confounders (i.e., full adjustment modeling
method) is a better approach [24].
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Overview of studies
After critical review of the 49 full text manuscripts, eight
studies met our inclusion criteria (Figure 1A, Additional file 1:
Table S1 and Additional file 2: Table S2). There were
distinct variations in quality across studies with respect
to defining and measuring physical inactivity, defining
and measuring T2DMand adjusting for confounders in
the final model for calculating PAF and follow up time
(Additional file 1: Table S1 and Additional file 2: Table S2).
Of the eight studies, three focused on the exposure of
‘total physical inactivity’ [26,37,38], three on leisure-
time activity and two on subsets of leisure-time activity -
specifically ‘exercise’ [39] and ‘sport’ [40] (Additional file 2:
Table S2). Of the eight studies, two described three differ-
ent prospective cohorts and six were reviews of published
data. The two prospective cohort studies (included three
prospective cohorts) [14] estimated PAF using full ad-
justment modeling. The six reviews estimated PAF using
published data of adjusted relative risk (RRadj) from previ-
ously published cohort studies and estimated the preva-
lence of physical inactivity (Pe) from cross-sectional data.
Physical inactivity was self- reported in all studies except
one that used data on prevalence of physical inactivity
measured by accelerometry [37].
Prospective cohort studies (2 studies, 3 prospective
cohorts)
The three prospective cohorts scored the highest on
quality assessment, Additional file 3: Table S3. The PAF
for physical inactivity ranged from 3% (95% CI: -11, 16)
to 29% (95% CI: 17, 41). In Finland, the PAF from two
prospective cohort studies for exercise, a subset of
leisure-time domain, ranged from 3% (95% CI: -11, 16)
to 7% (95% CI: -9, 20) [13]. The cumulative incidence
ranged from 2.6 to 3.9 per 100 people, the adjusted rela-
tive risk (RRadj) ranged from 1.28 (95% CI: 0.99, 1.48) to
1.35 (95% CI: 0.97, 1.6) and the prevalence of physical
inactivity (Pe) ranged from 24.1% and 36.5%. In the
USA, the PAF for sport, subset of leisure-time domain,
to range from 13% to 29%: 13% (95% CI: 3, 22) in men
and 29% (95% CI: 17, 41) in women [40]. The cumula-
tive incidence was 7.6 per 100 person, the adjusted rela-
tive risk (RRadj) was 1.21 (95% CI: 1.1, 1.35) for men
and 1.43 (95% CI: 1.21, 1.68) for women and the preva-
lence of physical activity (Pe) was 55.2% for men and
66.3% for women.
Country-specific reviews on published data (4 studies)
The PAF estimates from these four studies ranged from
20.1% (17.8, 30.1) [37] to 39% (95% CI: 35.9, 41.7) [38]
for total physical inactivity and 19.9% (95% CI: 11, 27.1)
[41] to 21.1% (16.5, 25.2) [42] for leisure-time activity.
The 95% confidence intervals were constructed for allPAF estimates using the substitution method [32]. The
adjusted relative risk (RRadj) ranged from 1.24 (95% CI:
1.1, 1.39) to 1.74 (95% CI: 1.65, 1.83) and the prevalence
of physical inactivity ranged from 19.8% to 82% for men
and 26.8% to 86.3% for women. The ranges of PAF,
RRadj and Pe estimates from these country-specific
studies were narrower than estimates generated from
the three prospective cohort studies.Global review on published data (2 studies)
In general, the global review studies [14,26] reported lower
PAFs than the country-specific reviews and the prospect-
ive cohort studies except for Finland. The review studies
had different definitions for physical inactivity [14,26]. Bull
[26] defined physical inactivity as total physical inactivity
while Lee [14] referred to leisure-time activity alone. Fur-
ther, these two reviews used different formulas containing
different denominators to calculate PAF from previously
published data (Additional file 1: Table S1 and Additional
file 2: Table S2) [14,26]. Bull’s [26] PAF estimates for total
physical inactivity ranged from 5.2% (95% CI: 2.2, 8.2) in
Canada to 13% (95% CI: 4.8, 16.6) in Finland for total
physical inactivity while Lee [14] estimated PAFs for
leisure-time to range from 7% (95% CI: 0.8, 14.4) in
Canada to 10.7% (95% CI: 5.4, 16.8) in South Africa. In
one review [26] the 95% CI intervals were not reported
therefore we reconstructed them using the substitution
method [32]. The adjusted relative risk (RRadj) 1.24
(1.1, 1.39) and the prevalence of physical inactivity ranged
from 23% to 61%.Discussion
A review of the variation that exists in PAF across the
existent literature
The PAF estimates for T2DM that is attributable to phys-
ical inactivity varied widely from 3%-39% across studies
(Janssen & Laksoonen). As determined from the perform-
ance on our quality assessment, the best quality data in
this systematic review suggest that the PAF of T2DM due
to physical inactivity in the USA for a non sport partici-
pant (never engaged in strenuous sports) ranged from
13% (95% CI: 3, 22) in men and 29% (95% CI: 17, 41) in
women. In Finland, Finland, the PAF of T2DM due to
physical inactivity for the occasional exerciser (≤30 min/day,
subset of leisure-time activity domain) ranged from 3%
(95% CI: -11, 16) to 7% (95% CI: -9, 20). The PAF esti-
mates for T2DM attributable to physical inactivity varied
widely. Specifically, further variation is notable across study
design, countries and sex. Such divergence may be ex-
plained by the distinct inconsistency in quality across
studies. Below we elaborate on how two categories relat-
ing to study methodology and statistical analysis con-
tribute to the observed variation in PAF estimates.
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demonstrated variation in PAF
Two main factors explain the wide variation we observe
in the PAF estimates for T2DM attributable to physical
inactivity: heterogeneous study methodology (i.e., study
design, exposure and outcome measurement) and statistical
methodology.
Methodology
Choice of study design
The choice of study design is a key factor that may explain
substantial variation PAF estimate. More recently, meth-
odological advances demonstrate that prospective cohort
studies are preferable for PAF estimation because the cal-
culations rely on censored time to event data [43,44,28].
Historically, there is a large body of literature estimating
PAF from case-control and cross sectional data [24]. For
example, only two of the eight studies included in this sys-
tematic review reported three prospective cohort studies
that were designed to estimate PAF as a primary outcome
measure. As such, we observed wide variation in PAF esti-
mates due to fundamental differences in study design. Sec-
ond, PAF is based on multiple assumptions. One of these
assumptions is that PAF assumes that risk factors precede
and be causally related to the outcome. This assumption
requires a longitudinal study design–a prospective cohort
study. Ignoring such assumptions can lead to inaccurate
estimations and hence incorrect interpretation of PAF
estimates. Lastly, length of followup is another critical
factor in accurately valuing PAF. In this systematic review,
the follow up period ranged from 5 to 20 years overall and
from 7 to 12 years in the three prospective cohort studies.
Importantly, short follow up times tend to overestimate
PAF and longer followup times generally underestimate
PAF [21].
Measurement of exposure (domain-specific PAF)
Another reason that could explain the observed degree
of variation in PAF is the use of different definitions for
the physical inactivity. Physical inactivity occurs when
total activity fails to meet the recommended guidelines
of ≥ 150 minutes of moderate-intensity or ≥ 75 minutes
of vigorous-intensity aerobic physical activity per week
in bouts of at least 10 minutes duration accumulated across
occupational, transport-related, domestic or leisure-time ac-
tivity domains [5]. Leisure–time activity consists of exercise,
sport [14,25,26]. Specifically, exercise and sports are unique
subsets of the leisure-time activity domain; they are not
interchangeable [27]. Therefore, acknowledging distinc-
tion between is essential in our interpretation of results
[27]. Two studies reporting three prospective cohorts
scored high in our quality assessment. Despite this, the
PAF estimates varied widely from 13% (3, 22) to 29%
(17, 41) for occasional exerciser (≤30 min/day) [13] and3% (-11, 16) to 7% (-9, 20) for non sport participants.
This could partially be explained by the use different
subsets definition of leisure-time domain. In the four
country-specific reviews, only two studies [41,42] used
similar definitions for the physical inactivity of the
leisure-time activity domain. In the two global review
studies, the PAFs ranged from 5.2% (2.2, 8.2) to 10.9%
(4.8, 16.6). These studies [14,26] also have different
definitions for physical inactivity. For example, Bull
[26] estimated PAF for total physical inactivity while
Lee [14] estimated PAF based primarily on the leisure-
time domain.
Another factor that could explain variation in PAF is
that physical activity was self reported in all studies ex-
cept one [37]. A higher PAF of 39% (35.9, 41.7) was
based on Canadian data [15]. One explanation for the
higher PAF observed may be due in part to how physical
inactivity is assessed. For example, using an objective
measure such as accelerometry is more likely to capture
total physical activity compared than a subjective meas-
ure (i.e., self report). Self reporting of physical inactivity
is prone to measurement error (i.e., often underestima-
tion of physical inactivity) and consequently biased PAF
(i.e., often overestimation) estimates. In a systematic re-
view, Prince [35] reported low-to-moderate correlations
between self-report and direct measures of physical in-
activity that ranged from -0.71 to 0.96. A clear trend for
the mean differences was not present. However, self-
report measures were 44% (range: -78% to 500%) higher
than those measured directly by accelerometers. This sug-
gests there is a trend of self-report measures over report-
ing physical activity leading to an under-estimation of
both physical inactivity and subsequent PAF estimates.Measurement of outcome
A third reason that could explain PAF estimate variation
is the use of different definitions for T2DM [30,45].
Current diagnostic criteria are fasting plasma ≥ 7.0 mmol/l
(126 mg/dl) or 2-h plasma glucose≥ 11.1 mmol/l (200 mg/dl)
[29,30]. Among the studies we reviewed, there were some
differences in methods of diagnosis of T2DM. None of the
studies included in this review was based solely on plasma
glucose.
Self- reported T2DM is also subject to measurement
bias. For instance, the accuracy of self-reported T2DM is
good (kappa = 0.78) and of moderate sensitivity (73%)
[46,47]. However, T2DM can remain asymptomatic for
at least 4 to 7 years before a clinical diagnosis is made.
[48]. As a result, T2DM may be undiagnosed in up to
50% of cases [49,50]. This underestimation of the inci-
dence of T2DM leads to an underestimate of RR and
PAF. Therefore, objective measurement of T2DM is de-
sirable for accurate PAF estimates.
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There are two published modeling techniques PAF: the
full adjustment method and the partial adjustment method.
Below we discuss the pros and cons of these methods in
the context of estimating the PAF of T2DM attributable
to physical inactivity.
Full adjustment method (modeling techniques)
In the two prospective studies PAF different modeling
techniques were used. Laaksonen used a piecewise constant
hazard model while Steinbrecher used Cox proportional
hazard model [21,24]. To reduce bias in PAF estimates and
account for death, Laaksonen [21] suggests using piecewise
over Cox model when the outcome of interest is disease.
Partial adjustment method (crude formula)
In the four country-specific review studies, the PAF was
calculated from published data of adjusted relative risk
(RRadj) using previously published cohort studies and
the prevalence of physical inactivity (prevalence of expos-
ure, Pe) was estimated from previously published cross
sectional surveys. In the presence of confounding, a popu-
lar method of calculating PAF is to use published adjusted
RR and estimated prevalence in the crude formula 1 [31]:
PAF ¼ Pe RRadj‐1ð Þ
Pe RRadj‐1ð Þ½  þ 1 100
This method is called partial adjustment. Partial ad-
justment is a common method when data on all known
confounders are not available or not measured. However,
formula 1 should only be used in the absence of con-
founding, because it assumes no confounding of the
exposure-outcome association [25]. Four of the country
specific review studies in this review used formula 1. In
the presence of confounding another variant formula is
recommended, formula 2 [31]:
PAF ¼ Pe RRadj‐1ð Þ
RRadj
 100
Only one global review study [14] used formula 2.
Severe confounding bias may occur with partial adjust-
ment method, especially formula 1, because the fraction
of the outcome that is attributable to the confounding
variables is not adequately adjusted [36]. For example,
one study demonstrated that partial adjustment for
confounding by age and sex yielded a 17% overestimation
in PAF [36]. Hence, the full adjustment method that
adjusts for all known confounders is a better choice
for estimating PAF.
Adjustment for confounders
In this review, over-adjustment or under-adjustment
(most likely) of known confounders varied explainingsome of the variation in PAF estimates [51]. For instance,
adjusting for intermediate variables as confounders can
lead to over-estimated or null-biased PAF [52]. There-
fore, adjustment should be limited to known evidence
based confounders.
Subgroup analysis (sex specific PAF)
PAF integrates and is directly related to relative risk
(RR) and the prevalence of physical inactivity (Pe) in the
population [53]. Thus, for a given RR, different preva-
lence estimates for physical inactivity yield different PAF
estimates and vice versa in a non linear fashion [53]. In
this review, one high quality prospective study reported
widely variable sex specific PAFs for non sport partici-
pants [40]: 29% (95% CI: 17, 41) for women and 13%
(95% CI: 3, 22) for men. In women, both the RRadj 1.43
(95% CI: 1.21, 168) and Pe 66.3% were higher than men:
RRadj 1.21 (1.1, 1.35) and Pe 55.2%, respectively. This
could explain sex difference observed in PAF estimates.
For example, Flegal [36] showed that a small difference
of 3% in age subgroup between the source population
and the target population lead to a 42% overestimation
in PAF. In addition PAF is sensitive to minor changes in
RR. A difference of 0.20 in RR almost doubled the PAF
estimate. This highlights the important of accurately
quantifying the RR and Pe prior to estimating PAF.
Limitations and strengths
This systematic review did not include a meta-analysis
because pooling was not appropriate due to the hetero-
geneity of studies at conceptual, operational, design and
statistical levels. Study heterogeneity was due in part to
the inclusion criteria for this systematic review. Specific-
ally, we included studies that estimated PAF or PAR
using modeling on raw data from a prospective cohort
design or (ii) that used published adjusted relative risk.
Further, data from each study on physical inactivity were
collected from different populations using different sam-
pling and estimation methods. These differences con-
tribute to the wide variation in PAF T2DM attributable
to physical inactivity. This is the first systematic review
that has ascertained the PAF T2DM attributable to phys-
ical inactivity. We believe the results of this systematic
review provide an essential platform for understanding
methodological and statistical reasons that underpin
current and widely varying PAF estimates. Further, this
study provides an initial step toward developing criteria to
report and evaluate PAFs in the future.
Conclusions
The best quality data from this systematic review indi-
cate the PAF of T2DM attributable to physical inactivity
should be considered and interpreted by domain and/or
subset of physical inactivity. In the USA, PAFs for sport
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http://www.biomedcentral.com/1471-2458/14/469ranged from 13% (95% CI: 3, 22) to 29% (95% CI: 17, 41):
13% (95% CI: 3, 22) in men and 29% (95% CI: 17, 41) in
women. In Finland, the PAFs for exercise ranged from 3%
(95% CI: -11, 16) to 7% (95% CI: -9, 20). The best study
design for estimating PAF is the prospective cohort. To
obtain the most accurate estimate of PAF the following
need to be implemented: objective measurement for ex-
posure (physical inactivity), objective measurement of out-
come (T2DM), full adjustment method that adjusted for
all known confounder and a piecewise model.
PAF is a valuable statistic in ascertaining burden of a
disease due to a specific risk factor from a public health
perspective only when it is accurately calculated using an
appropriate study design (i.e., a prospective cohort study).
Future studies estimating PAF could reduce the wide vari-
ability we currently observe in PAF data by using valid
and reliable methods to measures physical inactivity and
by using consistent ‘best practice’ methodology for
reporting PAF [21,54]. Such improvements in study de-
sign methodology and consistent cutting edge method-
ology will facilitate appropriate and well-informed public
health decision making choices.
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